Cover Image

Oxybutynin and tolterodine for treatment of neurogenic detrusor overactivity: a pharmacoeconomic evaluation in the Brazilian context

Antimuscarinic agents are the first-line choice for the treatment of neurogenic detrusor overactivity (NDO). The currently available antimuscarinic drugs have been widely studied in patients presenting idiopathic detrusor overactivity; however, investigations evaluating the effects of these drugs on...

Full description

Saved in:

Bibliographic Details
Main Authors:	Rodrigo Silva Suguino (Author), Gisele Martins (Author), Brunna Carvalho Viana Campos (Author), Raylayne Ferreira Bessa (Author), Démerson André Polli (Author), Mani Indiana Funez (Author), Cris Renata Grou Volpe (Author)
Format:	Book
Published:	Universidade de São Paulo, 2012-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Oxybutynin and tolterodine in a trial for treatment of overactive bladder in Iranian women.
by: Elham Aziminekoo, et al.
Published: (2014)

Pharmacokinetics of solifenacin in pediatric populations with overactive bladder or neurogenic detrusor overactivity
by: Stacey Tannenbaum, et al.
Published: (2020)

Clinical and urodynamic effects of tolterodine in women with an overactive bladder
by: Chiu-Lin Wang, et al.
Published: (2013)

Tolterodine Tartrate Proniosomal Gel Transdermal Delivery for Overactive Bladder
by: Rajan Rajabalaya, et al.
Published: (2016)

Treatment efficacy of tolterodine versus belladonna mixture in children with idiopathic overactive bladder
by: Zheming Xu, et al.
Published: (2019)

Hiperatividade do detrusor: comparação entre oxibutinina, eletroestimulação funcional do assoalho pélvico e exercícios perineais. Estudo randomizado Detrusor overactivity: comparative study among oxybutynin, functional electrostimulation and pelvic floor training. A randomized clinical trial
by: Raquel Martins Arruda, et al.
Published: (2007)

Oxybutynin extended release for the management of overactive bladder: a clinical review
by: AM Arisco, et al.
Published: (2009)

Concomitant Detrusor and External Urethral Sphincter Botulinum Toxin-A Injections in Male Spinal Cord Injury Patients with Detrusor Overactivity and Detrusor Sphincter Dyssynergia
by: Yu-Hui Huang, et al.
Published: (2022)

The role of muscarinic receptor subtypes on carbachol-induced contraction of normal human detrusor and overactive detrusor associated with benign prostatic hyperplasia
by: Tomonori Yamanishi, et al.
Published: (2015)

Herpes zoster-induced urologic and gastrointestinal dysfunction with residual neurogenic detrusor underactivity
by: Bianca Biglione, BS, et al.
Published: (2022)

Detrusor underactivity causes neurogenic voiding dysfunction in a rat bilateral accessory nerve-injury model
by: Kotomi Maeda, et al.
Published: (2021)

A foreseeable tissue engineering approach to overcome the neurogenic bladder-related detrusor/urethral rhabdosphincter dyssynergia
by: Contardo eAlberti
Published: (2014)

Pharmacoeconomic feasibility of using Mirabegron in patients with overactive bladder
by: I. N. Dyakov, et al.
Published: (2021)

The influence of pain on elderly diabetics' quality of life [A influência da dor na qualidade de vida de idosos portadores de Diabetes Mellitus] [La influencia del dolor en la calidad de vida de ancianos portadores de Diabetes Mellitus]
by: Fernanda Thais Ferreira de Paiva, et al.
Published: (2019)

Comparison of pain and quality of life between individuals with and without diabetic neuropathy
by: Ana Catarina Guimarães Silva, et al.
Published: (2021)

Muscarinic receptor binding of fesoterodine, 5-hydroxymethyl tolterodine, and tolterodine in rat tissues after the oral, intravenous, or intravesical administration
by: Shizuo Yamada, et al.
Published: (2019)

Mirabegron: pharmacoeconomic aspects of the use of the drug for the treatment of overactive bladder syndrome
by: O. I. Ivakhnenko, et al.
Published: (2022)

Asiatic Acid, a Natural Compound that Exerts Beneficial Effects on the Cystometric and Biochemical Parameters in the Retinyl Acetate-Induced Model of Detrusor Overactivity
by: Andrzej Wróbel, et al.
Published: (2021)

O-1602, an Agonist of Atypical Cannabinoid Receptors GPR55, Reverses the Symptoms of Depression and Detrusor Overactivity in Rats Subjected to Corticosterone Treatment
by: Andrzej Wróbel, et al.
Published: (2020)

Oxybutynin as an alternative treatment for hyperhidrosis
by: Sergio Delort, et al.
Published: (2017)

On the Absolute Stereochemistry of Tolterodine: A Circular Dichroism Study
by: Marcin Górecki, et al.
Published: (2019)

Oxybutynin treatment for buprenorphine-naloxone-induced hyperhidrosis
by: Lindsay McCormack, BA, et al.
Published: (2021)

Atypical aquagenic keratoderma treated with oxybutynin chloride
by: Niharika Dixit, et al.
Published: (2018)

OXYBUTYNIN IN TREATMENT OF HYPERACTIVE URINARY BLADDER IN CHILDREN
by: L.B. Menovshchikova, et al.
Published: (2009)

OXYBUTYNIN IN TREATMENT OF HYPERACTIVE URINARY BLADDER IN CHILDREN
by: L.B. Menovshchikova, et al.
Published: (2009)

Effectiveness of Short Term Percutaneous Tibial Nerve Stimulation for Non-neurogenic Overactive Bladder Syndrome in Adults: A Meta-analysis
by: Elita Wibisono, et al.
Published: (2015)

Inhibition of prejunctional parasympathetic pathways by β3-adrenoceptor agonists in the isolated pig detrusor: comparison with human detrusor studies
by: Gianluigi D'Agostino, et al.
Published: (2023)

Effects of a combination of herbal extracts (modified Ojayeonjonghwan (Wuzi Yanzong wan)) on partial urethral obstruction-induced detrusor overactivity in rats: impact on the nitric oxide pathway and oxidative stress
by: Sangrak Bae, et al.
Published: (2019)

Treatment of Non-neurogenic Overactive Bladder with OnabotulinumtoxinA: Systematic Review and Meta-analysis of Prospective, Randomized, Placebo-controlled Clinical Trials
by: Raquel Martins Arruda, et al.
Published: (2018)

Comparative in vitro assessment of tolterodine tartrate tablets by high performance liquid chromatographic (HPLC)
by: Hossein Danafar
Published: (2016)

Long-term results of oxybutynin use in treating facial hyperhidrosis
by: Nelson Wolosker, et al.
Published: (2014)

A case of probable oxybutynin-induced increase in liver enzymes
by: Alrawashdeh H, et al.
Published: (2018)

Effects of 4-Ethylamino-2-butynyl(2-cyclohexyl-2-phenyl)glycolate Hydrochloride, a Metabolite of Oxybutynin, on Bladder Specimens and Rhythmic Bladder Contraction in Rats in Comparison With Oxybutynin
by: Masayuki Uchida, et al.
Published: (2004)

Mechanism of Action by Which Aspirin Alleviates Detrusor Hyperactivity in Rats
by: Yasuhiro Tsukimi, et al.
Published: (2004)

The Modulation Of Detrusor Contractility By Agents Influencing Ion Channel Activity
by: Kocmálová M., et al.
Published: (2018)

Intravesical Oxybutynin for Urgent Bladder Rescue in a Newborn with Posterior Urethral Valves
by: Ada Molina Caballero, et al.
Published: (2019)

Repositioning Oxybutynin Hydrochloride: State of the Art in Synthesis, Mode of Action, Metabolism, and Formulations
by: Jean Jacques Vanden Eynde
Published: (2023)

Overactive bladder
by: Anna Zwierzyńska
Published: (2021)

Formulation of oxybutynin chloride microparticle-loaded suppositories: in vitro characterization and in vivo pharmacokinetic study
by: Anjali Bedse, et al.
Published: (2022)

A validated LCâMS/MS method for the determination of tolterodine and its metabolite in rat plasma and application to pharmacokinetic study
by: Rihana Parveen Shaik, et al.
Published: (2013)